Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease (Q32041582)

5 July 2017

title

Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington's disease (English)

1 reference

5 July 2017

0 references

0 references

Yu Z

1

1 reference

5 July 2017

Zhou D

series ordinal

2

1 reference

5 July 2017

Cheng G

series ordinal

3

1 reference

5 July 2017

Mattson MP

series ordinal

4

1 reference

5 July 2017

publication date

1 August 2000

1 reference

Journal of Molecular Neuroscience

5 July 2017

published in

1 reference

5 July 2017

volume

15

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

31-44

1 reference

Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease

5 July 2017

cites work

1 reference

12 December 2020

Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum

1 reference

12 December 2020

Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates

1 reference

12 December 2020

Mitochondrial defect in Huntington's disease caudate nucleus

1 reference

12 December 2020

Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats

1 reference

12 December 2020

The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons

1 reference

12 December 2020

IAP family proteins--suppressors of apoptosis

1 reference

12 December 2020

Nuclear factor-kappa B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment

1 reference

12 December 2020

Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors

1 reference

12 December 2020

Behavioral pathology induced by repeated systemic injections of 3-nitropropionic acid mimics the motoric symptoms of Huntington's disease

1 reference

12 December 2020

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

1 reference

12 December 2020

Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis

1 reference

12 December 2020

Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease

1 reference

12 December 2020

Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity

1 reference

12 December 2020

Secreted beta-amyloid precursor protein counteracts the proapoptotic action of mutant presenilin-1 by activation of NF-kappaB and stabilization of calcium homeostasis

1 reference

12 December 2020

Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice

1 reference

12 December 2020

Trinucleotide repeat length and clinical progression in Huntington's disease

1 reference

12 December 2020

Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons

1 reference

12 December 2020

Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults

1 reference

12 December 2020

Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75.

1 reference

12 December 2020

Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:15:1:31

1 reference

Dimensions Publication ID

5 July 2017

1028014067

0 references

1 reference